StonvexLoading…
StonvexStonvexStonvexCore line items from SCOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $91.64M | $85.32M | $357.47M | $264.00M | $175.10M |
Operating Income | Not available | $-4.52M | $4.51M | $-2.04M | $-3.75M |
Net Income | Not available | $-6.25M | $-10.00M | $-13.03M | $-9.49M |
EPS (Diluted) | $0.73 | $-0.41 | $4.25 | $-5.24 | $-4.41 |
Total Assets | Not available | $400.17M | $407.71M | $406.94M | $415.89M |
Total Liabilities | Not available | $205.52M | $206.55M | $225.73M | $230.09M |
Cash & Equivalents | Not available | $22.04M | $23.62M | $26.70M | $25.99M |
Free Cash Flow OCF − CapEx | Not available | $12.42M | $21.78M | $18.84M | $9.47M |
Shares Outstanding | Not available | 15.02M | 14.88M | 5.02M | 5.01M |